Use of Public Research and Manufacturing Enterprises to Lower Prescription Drug Prices and Increase Innovation

被引：0

作者：

Moss, Alex ^{[1
]}

Brown, Dana ^{[2
]}

Tu, S. Sean ^{[3
]}

机构：

[1] Publ Interest Patent Law Inst, Los Angeles, CA 92253 USA

[2] Democracy Collaborat, Washington, DC USA

[3] West Virginia Univ, Coll Law, Morgantown, WV USA

来源：

JOURNAL OF LAW MEDICINE & ETHICS | 2024年 / 52卷 / 03期

关键词：

Medicare; Prescription Drug Spending;

D O I：

10.1017/jme.2024.142

中图分类号：

B82 [伦理学（道德学）];

学科分类号：

摘要：

This article proposes building on the success of publicly funded drug research and development and expanding the model to include the full cycle development, testing, manufacture and distribution of innovative and affordable new drugs.

引用

页码：750 / 754

页数：5